Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over time

Breast Cancer Research and Treatment

Volumn 140, Issue 2, 2013, Pages 285-297

  Chew, G L ^a   Huang, D ^a   Huo, C W ^a   Blick, T ^b   Hill, P ^a   Cawson, J ^a   Frazer, H ^a   Southey, M D ^a   Hopper, J L ^a   Henderson, M A ^c   Haviv, I ^a,d   Thompson, E W ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d BAR ILAN UNIVERSITY   (Israel)

Author keywords

Bioengineering chambers; Lactation; Mammographic density; Postpartum involution; Stroma; Xenograft

Indexed keywords

ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LACTATION; MAMMOGRAPHIC DENSITY; MAMMOGRAPHY; MASTECTOMY; MOUSE; NONHUMAN; NULLIPARA; PERINATAL PERIOD; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; STROMA; TISSUE ENGINEERING; TUMOR XENOGRAFT; ANIMAL; BREAST; BREAST TUMOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; MAMMARY GLAND; PATHOLOGY; PREGNANCY;

ANIMALS; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; MICE; PERIPARTUM PERIOD; PREGNANCY; TISSUE ENGINEERING;

EID: 84881439510     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2642-7     Document Type: Article

References (45)

1. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227-236. doi: 10.1056/NEJMoa062790
2. McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159-1169. doi: 10.1158/1055-9965.EPI-06-0034
3. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12(4):332-338
4. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87(21):1622-1629
5. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87(9):670-675
6. Wolfe JN, Saftlas AF, Salane M (1987) Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol 148(6):1087-1092
7. Byrne C, Schairer C, Brinton LA, Wolfe J, Parekh N, Salane M, Carter C, Hoover R (2001) Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 12(2):103-110
8. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43(2):209-221
9. Franceschi S (1989) Reproductive factors and cancers of the breast, ovary and endometrium. Eur J Cancer Clin Oncol 25(12):1933-1943
10. Brinton LA, Schairer C, Hoover RN, Fraumeni JF Jr (1988) Menstrual factors and risk of breast cancer. Cancer Invest 6(3):245-254
11. Britt K, Short R (2012) The plight of nuns: hazards of nulliparity. Lancet 379(9834):2322-2323. doi: 10.1016/S0140-6736(11)61746-7
12. Purdie DM, Bain CJ, Siskind V, Webb PM, Green AC (2003) Ovulation and risk of epithelial ovarian cancer. Int J Cancer 104(2):228-232. doi: 10.1002/ijc.10927
13. Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N (2005) The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14(2):343-349. doi: 10.1158/1055-9965.EPI-04-0490
14. Martin LJ, Minkin S, Boyd NF (2009) Hormone therapy, mammographic density, and breast cancer risk. Maturitas 64(1):20-26. doi: 10.1016/j.maturitas.2009.07.009
15. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95(1):30-37
16. Lundstrom E, Christow A, Kersemaekers W, Svane G, Azavedo E, Soderqvist G, Mol-Arts M, Barkfeldt J, von Schoultz B (2002) Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 186(4):717-722
17. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285(2):171-176
18. Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103(9):744-752. doi: 10.1093/jnci/djr079
19. Chew GL, Huang D, Lin SJ, Huo C, Blick T, Henderson MA, Hill P, Cawson J, Morrison WA, Campbell IG, Hopper JL, Southey MC, Haviv I, Thompson EW (2012) High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers. Breast Cancer Res Treat 135(1):177-187. doi: 10.1007/s10549-012-2128-z
20. Lin SJ, Cawson J, Hill P, Haviv I, Jenkins M, Hopper JL, Southey MC, Campbell IG, Thompson EW (2011) Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue. Breast Cancer Res Treat 128(2):505-516. doi: 10.1007/s10549-011-1346-0
21. Boyd NF, Melnichouk O, Martin LJ, Hislop G, Chiarelli AM, Yaffe MJ, Minkin S (2011) Mammographic density, response to hormones, and breast cancer risk. J Clin Oncol 29(22):2985-2992. doi: 10.1200/JCO.2010.33.7964
22. Kelly JL, Findlay MW, Knight KR, Penington A, Thompson EW, Messina A, Morrison WA (2006) Contact with existing adipose tissue is inductive for adipogenesis in matrigel. Tissue Eng 12(7):2041-2047. doi: 10.1089/ten.2006.12. 2041
23. Stillaert F, Findlay M, Palmer J, Idrizi R, Cheang S, Messina A, Abberton K, Morrison W, Thompson EW (2007) Host rather than graft origin of matrigel-induced adipose tissue in the murine tissue-engineering chamber. Tissue Eng 13(9):2291-2300. doi: 10.1089/ten.2006.0382
24. Thomas GP, Hemmrich K, Abberton KM, McCombe D, Penington AJ, Thompson EW, Morrison WA (2008) Zymosan-induced inflammation stimulates neo-adipogenesis. Int J Obes (Lond) 32(2):239-248. doi: 10.1038/sj.ijo.0803702
25. Rosen PP (ed) (2009) Rosen's breast pathology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia
26. Richert MM, Schwertfeger KL, Ryder JW, Anderson SM (2000) An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 5(2):227-241
27. Albrektsen G, Heuch I, Hansen S, Kvale G (2005) Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer 92(1):167-175. doi: 10.1038/sj.bjc.6602302
28. Schedin P (2006) Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6(4):281-291. doi: 10.1038/nrc1839
29. Wohlfahrt J, Melbye M (2001) Age at any birth is associated with breast cancer risk. Epidemiology 12(1):68-73
30. Milne RL, John EM, Knight JA, Dite GS, Southey MC, Giles GG, Apicella C, West DW, Andrulis IL, Whittemore AS, Hopper JL (2011) The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry. Int J Epidemiol 40(5):1342-1354. doi: 10.1093/ije/dyr110
31. Lope V, Perez-Gomez B, Sanchez-Contador C, Santamarina MC, Moreo P, Vidal C, Laso MS, Ederra M, Pedraz-Pingarron C, Gonzalez-Roman I, Garcia-Lopez M, Salas-Trejo D, Peris M, Moreno MP, Vazquez-Carrete JA, Collado F, Aragones N, Pollan M (2012) Obstetric history and mammographic density: a population-based cross-sectional study in Spain (DDM-Spain). Breast Cancer Res Treat. doi: 10.1007/s10549-011-1936-x
32. Loehberg CR, Heusinger K, Jud SM, Haeberle L, Hein A, Rauh C, Bani MR, Lux MP, Schrauder MG, Bayer CM, Helbig C, Grolik R, Adamietz B, Schulz-Wendtland R, Beckmann MW, Fasching PA (2010) Assessment of mammographic density before and after first full-term pregnancy. Eur J Cancer Prev 19(6):405-412. doi: 10.1097/CEJ.0b013e32833ca1f4
33. Sung J, Song YM, Stone J, Lee K, Lee D (2011) Reproductive factors associated with mammographic density: a Korean co-twin control study. Breast Cancer Res Treat 128(2):567-572. doi: 10.1007/s10549-011-1469-3
34. Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, Kuperwasser C (2007) Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res 67(5):2062-2071. doi: 10.1158/0008-5472.CAN-06-3895
35. Couto E, Qureshi SA, Hofvind S, Hilsen M, Aase H, Skaane P, Vatten L, Ursin G (2012) Hormone therapy use and mammographic density in postmenopausal Norwegian women. Breast Cancer Res Treat 132(1):297-305. doi: 10.1007/s10549-011-1810-x
36. van Duijnhoven FJ, Peeters PH, Warren RM, Bingham SA, van Noord PA, Monninkhof EM, Grobbee DE, van Gils CH (2007) Postmenopausal hormone therapy and changes in mammographic density. J Clin Oncol 25(11):1323-1328. doi: 10.1200/JCO.2005.04.7332
37. Bemis LT, Schedin P (2000) Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res 60(13):3414-3418
38. Schenk S, Hintermann E, Bilban M, Koshikawa N, Hojilla C, Khokha R, Quaranta V (2003) Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 161(1):197-209. doi: 10.1083/jcb.200208145
39. Lyons TR, O'Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW, Marusyk A, Tan AC, Schedin P (2011) Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 17(9):1109-1115. doi: 10.1038/nm.2416
40. Schedin P, Keely PJ (2011) Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol 3(1):a003228. doi: 10.1101/cshperspect.a003228
41. Strange R, Li F, Saurer S, Burkhardt A, Friis RR (1992) Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development 115(1):49-58
42. Streuli CH, Schmidhauser C, Kobrin M, Bissell MJ, Derynck R (1993) Extracellular matrix regulates expression of the TGF-beta 1 gene. J Cell Biol 120(1):253-260
43. Nguyen AV, Pollard JW (2000) Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 127(14):3107-3118
44. Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P, Lerma E (2007) Radiologic evaluation of breast disorders related to pregnancy and lactation. Radiographics 27(Suppl 1):S101-S124. doi: 10.1148/rg.27si075505
45. Ghosh K, Brandt KR, Reynolds C, Scott CG, Pankratz VS, Riehle DL, Lingle WL, Odogwu T, Radisky DC, Visscher DW, Ingle JN, Hartmann LC, Vachon CM (2012) Tissue composition of mammographically dense and non-dense breast tissue. Breast Cancer Res Treat 131(1):267-275. doi: 10.1007/s10549-011-1727-4